MTHFR Support

Addictive Behaviour

Understanding the complex nature of addictive behaviour involves exploring various factors that contribute to its development. One such crucial element is genetics. Our genes play a significant role in shaping who we are, and emerging research suggests a strong link between genetic factors and addictive behaviours. At MTHFR support Australia we aim to delve into the genetic basis of addictive behaviour, shedding light on how our DNA can influence susceptibility to addiction.

Genetic Predisposition:

Addiction is a multifaceted phenomenon influenced by a combination of genetic, environmental, and neurological factors. Some individuals may be genetically predisposed to addictive behaviours, making them more vulnerable to developing substance abuse issues. Studies on twins and families have consistently shown that there is a hereditary component to addiction risk.

Genes and Neurotransmitters:

Genes encode the production of proteins, including those involved in the regulation of neurotransmitters in the brain. Neurotransmitters are chemicals that transmit signals between nerve cells, and imbalances in their levels can contribute to addictive tendencies. Dopamine, a neurotransmitter associated with pleasure and reward, is particularly relevant to addiction. Genetic variations can impact the way dopamine is processed, influencing an individual’s response to substances and addictive behaviours.

Reward Pathways:

The brain’s reward system, primarily centred around the release of dopamine, plays a crucial role in addiction. Genetic variations can affect the structure and function of key components in this system, influencing how individuals experience and seek rewards. Some people may have a heightened sensitivity to rewarding stimuli, making them more susceptible to the reinforcing effects of addictive substances.

Risk Genes and Specific Addictions:

Research has identified specific genes associated with an increased risk of certain addictions. For example, variations in the genes encoding receptors for nicotine, alcohol, opioids, and other substances can contribute to the development of dependence on these substances. Understanding these genetic markers can help identify individuals who may be more vulnerable to specific types of addiction, allowing for targeted interventions and prevention strategies.

Here are some key genes that have been studied in relation to addiction:

1. Dopamine Receptor Genes (DRD2, DRD3, DRD4):

Dopamine is a neurotransmitter central to the brain’s reward system. Variations in genes that encode dopamine receptors, such as DRD2, DRD3, and DRD4, have been associated with increased susceptibility to addiction. These variations can affect the way individuals respond to rewarding stimuli.

2. Opioid Receptor Genes (OPRM1):

The mu-opioid receptor, encoded by the OPRM1 gene, plays a role in the brain’s response to opioids. Genetic variations in OPRM1 have been linked to opioid dependence and sensitivity to opioid medications.

3. Nicotine Receptor Genes (CHRNA5, CHRNA3, CHRNB4):

Genes encoding nicotine receptors, such as CHRNA5, CHRNA3, and CHRNB4, are associated with nicotine dependence. Variations in these genes can influence an individual’s susceptibility to nicotine addiction.

4. Alcohol Metabolism Genes (ADH and ALDH):

Genes involved in the metabolism of alcohol, such as alcohol dehydrogenase (ADH) and aldehyde dehydrogenase (ALDH), can impact an individual’s response to alcohol. Genetic variations in these genes can influence alcohol tolerance and dependence.

5. COMT (Catechol-O-methyltransferase):

This gene is involved in the breakdown of dopamine in the prefrontal cortex. Variations in COMT have been linked to differences in cognitive function and response to rewards, potentially influencing susceptibility to addiction. The COMT gene, which stands for Catechol-O-methyltransferase, plays a crucial role in the breakdown of neurotransmitters, including dopamine, in the brain. Dopamine is a neurotransmitter that is central to the brain’s reward system and is involved in various functions, including motivation, pleasure, and reinforcement of rewarding behaviours. The COMT gene influences the activity of the COMT enzyme, which is responsible for metabolizing dopamine and other catecholamines.

There are two common variants (polymorphisms) of the COMT gene: the Val158Met (rs4680) polymorphism. This genetic variation results in the substitution of valine (Val) for methionine (Met) at position 158 in the COMT enzyme.

The Val158Met polymorphism affects the activity of the COMT enzyme, leading to differences in dopamine degradation. The two variants have different enzymatic activities:

1. Val/Val Genotype:

Individuals with the Val/Val genotype have higher COMT enzyme activity. This increased activity results in more efficient breakdown of dopamine. As a consequence, individuals with the Val/Val genotype tend to have lower levels of dopamine in the prefrontal cortex.

2. Met/Met Genotype:
On the other hand, individuals with the Met/Met genotype have lower COMT enzyme activity, leading to less efficient breakdown of dopamine. This results in higher levels of dopamine in the prefrontal cortex.
6. BDNF (Brain-Derived Neurotrophic Factor):

BDNF is involved in the growth and maintenance of neurons. Variations in the BDNF gene have been associated with increased vulnerability to addiction, particularly in relation to substances like cocaine and methamphetamine.

7. CNR1 (Cannabinoid Receptor 1):

This gene encodes the cannabinoid receptor 1, which is part of the endocannabinoid system. Variations in CNR1 have been linked to cannabis dependence and may influence susceptibility to other addictive behaviours.

Epigenetics & Our environment:

Environmental factors play a crucial role in the development and progression of addiction. While genetic predisposition contributes to an individual’s vulnerability, it is the interaction between genetics and the environment that largely shapes the risk of addiction. Here are ways in which environmental factors can influence addiction:

Early Life Experiences:
  • Adverse childhood experiences, including trauma, abuse, neglect, and family dysfunction, can significantly impact the risk of developing addiction later in life.
  • Early exposure to stressors may lead to maladaptive coping mechanisms, such as substance use, as individuals seek relief from emotional pain or distress.
Family and Social Environment:
  • Family dynamics, parental substance use, and the availability of substances within the home can influence an individual’s attitudes toward and access to drugs or alcohol.
  • Peer influence also plays a significant role, as individuals may be more likely to engage in substance use if it is normalized or encouraged within their social circles.
Socioeconomic Factors:
  • Socioeconomic status can affect access to education, employment opportunities, and healthcare, influencing an individual’s susceptibility to addiction.
  • Economic disparities may contribute to stressors that increase the risk of substance use as a coping mechanism.
Community and Cultural Factors:
  • Cultural attitudes toward substance use and societal norms can shape an individual’s beliefs and behaviours.
  • Communities with high rates of substance availability, limited access to education, and few recreational opportunities may be more vulnerable to addiction-related issues.
Trauma and Stressors:
  • Exposure to chronic stress, trauma, or major life events can increase the risk of addiction.
  • Substance use may be used as a way to cope with stressors or to escape from the emotional impact of traumatic experiences.
Accessibility of Substances:
  • The availability and accessibility of addictive substances, including alcohol and illicit drugs, can strongly influence patterns of use.
  • Easy access to substances may contribute to experimentation and regular use, especially among individuals in environments where substance use is prevalent.
Media Influence:
  • Media, including advertising and popular culture, can shape perceptions of substance use and contribute to the normalization of certain behaviours.
  • Exposure to glamorized portrayals of substance use in the media may influence attitudes and behaviours.
Educational Opportunities:
  • Access to quality education and information about the risks of substance use can impact an individual’s awareness and decision-making regarding drug and alcohol consumption.
Availability of Treatment Services:
  • The availability and accessibility of addiction treatment services can influence an individual’s ability to seek and receive help for substance use disorders.
While genetics plays a significant role in addictive behaviour, it is essential to recognize that it is just one piece of the puzzle. Environmental factors, individual experiences, and behavioural choices also contribute to the development of addiction. Understanding the genetic basis of addictive behaviour opens the door to personalized approaches for prevention, intervention, and treatment, ultimately improving our ability to address this challenging public health issue.

Get support Now


Genetic Testing and First Appointment


Dopamine support pack

You must speak to a practitioner to get a personalised prescription.

How might specific amino acids support your addiction?

Tyrosine is an amino acid that serves as a precursor to several important neurotransmitters, including dopamine. Dopamine is a crucial neurotransmitter involved in the brain’s reward system, motivation, and pleasure. The relationship between tyrosine, dopamine, and addiction is complex and involves multiple factors.

Tyrosine as a Precursor to Dopamine:
  • Tyrosine is converted to L-DOPA, which is further converted to dopamine through a series of enzymatic reactions in the brain.
  • Adequate levels of tyrosine are essential for maintaining the synthesis of dopamine. Therefore, a lack of tyrosine may contribute to a reduction in dopamine levels.
Dopamine and the Reward System:
  • Dopamine plays a central role in the brain’s reward system. It is released in response to rewarding stimuli and reinforces behaviours associated with pleasure.
  • In the context of addiction, substances or activities that trigger a release of dopamine can become strongly associated with reward, leading to compulsive behaviours aimed at obtaining the rewarding stimulus.
Impact of Low Dopamine Levels:
  • Low dopamine levels or impaired dopamine transmission have been implicated in various psychiatric conditions, including addiction.
  • Individuals with lower dopamine levels may experience reduced motivation, decreased ability to experience pleasure (anhedonia), and difficulties in regulating mood and impulse control.
Addiction and Self-Medication:
  • Some individuals with lower dopamine levels may be more prone to engaging in addictive behaviours as a way of self-medicating to temporarily boost dopamine levels.
  • Drugs and activities that increase dopamine release provide a transient sense of pleasure and reward, which can be particularly appealing to those with underlying dopamine deficiencies.
Treatment Implications:

In certain cases, addressing nutritional factors, including ensuring an adequate supply of tyrosine and other precursors, may be considered as part of a comprehensive treatment approach.

Pharmacological interventions that target the dopamine system, such as medications used in the treatment of some substance use disorders, aim to restore a balance in neurotransmitter function.

It’s important to note that while neurotransmitter imbalances, including low dopamine levels, are associated with addiction, addiction is a complex condition influenced by a combination of genetic, environmental, and psychological factors. Additionally, the relationship between neurotransmitters and behaviour is bidirectional, meaning that addictive behaviours themselves can influence neurotransmitter function. Professional assessment and individualized treatment plans are crucial for addressing addiction and related issues.

Patient Knowledge Centre

Love to learn?  Looking for solutions and treatment plans?  Our Patient Knowledge Centre is an amazing resource centre with 100’s of hours of webinars and treatment protocols to empower you to keep you and your family healthy. And the best bit? Every month you get the chance to get your questions answered LIVE by Carolyn Ledowsky.

Scroll to Top
Complete Genetic Health Package
Complete Genetic Health Package

Complete Genetic Health Package

AUD $1118

AUD $919 +GST

SAVE $200


  • smartDNA Genetic Test (Valued at
    AUD $440.00 + Shipping + GST if applicable)
  • Initial 1.5 hour practitioner appointment (Valued at AUD $415)
  • 3 month free membership to the Patient Knowledge Centre – this is your one
    stop place for resources, education, downloads for anyone looking for answers to their health issues
  • 10% of all supplements included with your pack and PKC membership saving you
    at least AUD $20 per month
  • Free 15 minute appointment with Elyse our clinic manager to match you with
    your ideal practitioner (Valued at AUD $65)
  • Access to our dedicated Facebook community, to connect with others
    experiencing similar health concerns
  • Our ‘what is MTHFR’ ebook (Valued at AUD $59)
Carolyn Ledowsky

Stay Connected!

Sign up for our monthly newsletter with current MTHFR research, health tips, recipes, special offers and news about upcoming events including Carolyn’s live Q&A.